Page 1104 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1104

Chapter 78Severe Malaria
                             Sanjeev Krishna Arjen M. Dondorp



                   REFERENCES

                    1. Poser C, Bruyn G. An Illustrated history of Malaria. New York:     15. Crawley J, Chu C, Mtove G, Nosten F. Malaria in children.
                      Parthenon Publishing Group; 1999.                      Lancet. April 24, 2010;375(9724):1468-1481.
                    2. Hawass Z, Gad YZ, Ismail S, et al. Ancestry and pathology in King     16. ter Kuile FO, White NJ, Holloway PA, Pasvol G, Krishna S.
                      Tutankhamun’s family. JAMA. February 17, 2010;303(7):638-647.  Plasmodium falciparum:  in vitro studies of the pharmacody-
                    3. Laveran A. Paludism. Vol CXLVI. London: The New Sydenham   namic properties of antimalarials used for the treatment of
                      Society; 1893.                                         severe malaria. Exp Parasitol. 1993;76:85-95.
                    4. Cox-Singh J, Singh B, Krishna S. Plasmodium knowlesi: the fifth     17. Staines HM, Derbyshire ET, Slavic K, Tattersall A, Vial H,
                      human malarial parasite. In: Scheld WM, Grayson ML, Hughes   Krishna S. Exploiting the therapeutic potential of Plasmodium
                      JM, eds. Emerging Infections. Vol 9. ASM Press, Washington DC;   falciparum solute transporters.  Trends Parasitol. June
                      2010:261-271.                                          2010;26(6):284-296.
                    5. WHO. WHO malaria reports. 2010.  http://www.who.int/    18. Su X-z, Heatwole VM, Wertheimer SP, et al. The large diverse
                      malaria/world_malaria_report_2010/malaria2010_summary_  gene family var encodes proteins involved in cytoadherence and
                      keypoints_en.pdf. Accessed June 15, 2011.              antigenic variation of Plasmodium falciparum-infected eryth-
                                                                             rocytes. Cell. 1995;82:89-100.
                    6. Price L, Planche T, Rayner C, Krishna S. Acute respiratory
                      distress syndrome in Plasmodium vivax malaria: case report     19. Dondorp AM, Ince C, Charunwatthana P, et al. Direct in vivo
                      and review of the literature.  Trans R Soc Trop Med Hyg. July   assessment of microcirculatory dysfunction in severe falci-
                      2007;101(7):655-659.                                   parum malaria. J Infect Dis. January 1, 2008;197(1):79-84.
                                                                           20. Wassmer SC, Taylor T, Maclennan CA, et al. Platelet-induced
                    7. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM.
                      Vivax malaria: neglected and not benign. Am J Trop Med Hyg.   clumping  of  Plasmodium  falciparum-infected  erythrocytes
                      December 2007;77(6 suppl):79-87.                       from Malawian patients with cerebral malaria-possible modu-
                                                                             lation in vivo by thrombocytopenia.  J Infect Dis. January 1,
                    8. Cox-Singh J, Hiu J, Lucas SB, et al. Severe malaria—a case of   2008;197(1):72-78.
                      fatal Plasmodium knowlesi infection with post-mortem find-
                      ings: a case report. Malar J. 2010;9:10.             21. Dondorp AM, Angus BJ, Hardeman MR, et al. Prognostic sig-
                                                                             nificance of red cell deformability in severe falciparum malaria.
                    9. White N. Malaria. In: Cook G, Zumla A, eds.  Manson’s   Am J Trop Med Hyg. 1997;57:507-511.
                      Tropical Diseases. Vol 1. 22nd ed. China: Saunders Elsevier;
                      2009:1201-1300.                                      22. Udomsangpetch R, Thanikkul K, Pukrittayakamee S, White NJ.
                                                                             Rosette formation by Plasmodium vivax. Trans R Soc Trop Med
                   10. White NJ, Krishna S. Treatment of malaria: some considerations   Hyg. 1995;89:635-637.
                      and limitations of current methods of assessment. Trans R Soc
                      Trop Med Hyg. 1989;83:767-777.                       23. Carvalho BO, Lopes SC, Nogueira PA, et al. On the cytoadhe-
                                                                             sion of Plasmodium vivax-infected erythrocytes.  J Infect Dis.
                   11. Feachem  RG, Phillips  AA, Hwang  J,  et  al.  Shrinking  the   August 15, 2010;202(4):638-647.
                      malaria map: progress and prospects.  Lancet. November 6,     24. Cox-Singh J, Singh B, Daneshvar C, Planche T, Parker-Williams J,
                      2010;376(9752):1566-1578.
                                                                             Krishna S. Anti-inflammatory cytokines predominate in
                   12. Piel FB, Patil AP, Howes RE, et al. Global distribution of the   acute human Plasmodium knowlesi infections. PLoS One.
                      sickle cell gene and geographical confirmation of the malaria   2011;6(6):e20541.
                      hypothesis. Nat Commun. 2010;1:104.
                                                                           25. Warrell DA, Looareesuwan S, Warrell MJ, et al. Dexamethasone
                   13. Howes RE, Patil AP, Piel FB, et al. The global distribution of the   proves deleterious in cerebral malaria. A double-blind trial in
                      Duffy blood group. Nat Commun. 2011;2:266.             100 comatose patients. N Engl J Med. 1982;306:313-319.
                   14. Newton CW, Krishna S. Severe falciparum malaria in children:     26. Silamut K, Phu NH, Whitty C, et al. A quantitative analysis
                      current understanding of its pathophysiology and  supportive   of the microvascular sequestration of malaria parasites in the
                      treatment. Pharmacol Ther. 1998;79:1-53.               human brain. Am J Pathol. 1999;155(2):395-410.










          Section05-O-ref.indd   1                                                                                   1/20/2015   4:51:25 PM
   1099   1100   1101   1102   1103   1104   1105   1106   1107   1108   1109